Is ROL a Buy or a Sell? The Bull and Bear Case (2026)

Last updated October 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Rollins (ROL) rests on Recurring, non-discretionary demand: Pest and termite control is largely a need-to-do service, not a discretionary purchase, so a large portion of Rollins revenue recurs on contracts and repeat routes. The bear case rests on valuation is the central risk: ROL trades at a premium earnings multiple (about 30 times trailing earnings in October 2026) that assumes years of consistent growth, and 2026 has shown how a slowdown compresses it: after growth eased to ~8% and Q2 EPS missed, the market value fell from ~$20 billion in July to ~$16.1 billion. Analysts covering it publish targets from $27.00 to $66.00 against a $33.45 price, so even the professionals disagree by 96% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Rollins, Inc. is a US-based consumer and commercial services company that provides pest and termite control through a family of brands led by Orkin, alongside HomeTeam Pest Defense, Clark Pest Control, Fox Pest Control, Critter Control, Trutech, and many others across the US, Canada, Australia, and other markets. The business is built on recurring, contract-based service routes: residential pest control, commercial pest control, and termite and ancillary services, with a large share of revenue tied to repeat visits that give it visibility and pricing power. Rollins grows both organically (price and new customers) and through a steady stream of small tuck-in acquisitions of local operators in a highly fragmented industry. The investment picture is one of a defensive compounder. Demand for pest control is largely non-discretionary and recession-resistant, and Rollins pairs mid-single-digit organic growth with acquisition-driven revenue and consistent free cash flow that funds a growing dividend and buybacks. The debate centers on valuation and margins: the stock carries a premium multiple that reflects its quality and consistency, and recent quarters have shown some operating-margin compression from acquisition mix and cost inflation even as revenue growth stayed strong. The second quarter of 2026 sharpened that debate. Revenue rose ~7.9% year over year to ~$1.08 billion, slower than the ~10% pace of early 2026, and EPS of $0.32 missed the ~$0.34 consensus after an in-line Q1 and a Q4 2025 miss. Over the trailing twelve months Rollins earned ~$532 million on ~$3.92 billion of revenue, with ~$502 million of free cash flow. The market value has slipped to ~$16.1 billion as of October 16, 2026, from roughly $20 billion in July, bringing the trailing P/E down to ~30 from the high 30s.

The bull case: what would have to be true for $66.00

The most optimistic published target on ROL is $66.00, +97.3% from the $33.45 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Recurring, non-discretionary demand

Pest and termite control is largely a need-to-do service, not a discretionary purchase, so a large portion of Rollins revenue recurs on contracts and repeat routes. That gives the business unusual visibility and resilience through economic cycles. It is the foundation of the company's steady mid-single-digit organic growth.

2. Acquisition roll-up in a fragmented market

The pest-control industry is highly fragmented across thousands of regional operators, and Rollins runs a continuous program of small tuck-in acquisitions to add density and customers. In early 2026 it closed several deals and announced the roughly $90 million Romex Pest Control acquisition. This roll-up strategy has added several points of growth on top of the organic base for years.

3. Pricing power and route density

Scale and high route density let Rollins service more customers per technician mile, supporting margins and letting it pass through inflation via annual price increases. Residential, commercial, and termite lines all grew in the high single to low double digits in recent quarters. The combination of pricing plus volume drives durable top-line compounding. The pace has eased in 2026: total revenue growth slowed to ~7.9% in Q2 from ~10% in Q1, so pricing and density gains are carrying a little less volume growth than a year ago.

4. Cash generation funding dividend and buybacks

Rollins is asset-light and strongly cash-generative, converting a high share of earnings into free cash flow. That funds a regularly raised dividend, share repurchases, and the acquisition pipeline without heavy leverage. The capital-return profile is a core part of the long-term total-return story.

5. Q3 results and the re-rated multiple

Rollins reports Q3 2026 on October 21, 2026. Consensus is ~$0.35 of EPS on ~$1.11 billion of revenue, essentially flat with the $0.35 earned a year earlier, after two of the last four quarters fell short of estimates. Analysts expect ~$1.16 of EPS for 2026 and ~$1.28 for 2027 on revenue of ~$4.08 billion and ~$4.43 billion. With the trailing P/E down to ~30 from the high 30s and the 17 analysts tracked at a hold consensus (mean target near $41), the quarter tests whether the multiple has reset for slower growth or still has further to adjust.

The bear case: what would have to be true for $27.00

The most pessimistic published target is $27.00, -19.3% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Rollins is worth if the risks below bite instead of the drivers above.

Valuation is the central risk: ROL trades at a premium earnings multiple (about 30 times trailing earnings in October 2026) that assumes years of consistent growth, and 2026 has shown how a slowdown compresses it: after growth eased to ~8% and Q2 EPS missed, the market value fell from ~$20 billion in July to ~$16.1 billion. Operating margins have shown some compression recently from acquisition mix and cost inflation, and a heavy reliance on M&A carries integration and overpayment risk. Organic growth can soften with a weak housing market or unusually mild weather that reduces pest activity. Competition from Rentokil (which now owns Terminix), Ecolab, Aptive, and well-funded private-equity roll-ups could pressure pricing and deal prices. Labor availability and wage inflation for technicians are ongoing cost pressures. Balance-sheet flexibility is lower than it once was, with ~$1.12 billion of debt against ~$109 million of cash, and the dividend now takes about 65% of earnings.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding ROL already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on ROL

17 analysts cover ROL, with an average target of $40.76 (+21.9% against $33.45) and a split of 7 buy, 10 hold, 2 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the ROL forecast and price target page.

How is ROL valued? (as of October 2026)

Price

$33.45

Market cap

$16.09B

P/E (TTM)

30.41

Forward P/E

26.10

Price / book

11.26

Beta

0.73

52-week range

$29.29 to $66.14

Snapshot for ROL as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Revenue (TTM): ~$3.92B
Q2 2026 revenue: ~$1.08B (+7.9%)
Net income (TTM): ~$532M (Q2 2026 EPS $0.32 vs ~$0.34 expected)
Margins (TTM): ~52% gross, ~19% operating, ~14% net
Market cap: ~$16.1B (October 16, 2026)
P/E (trailing / forward): ~30.5x / ~26x
Dividend yield: ~2.2% ($0.73 a year)
Free cash flow (TTM): ~$502M

Rollins grew FY2025 revenue about 11% to roughly $3.8 billion, with organic growth near 7%, but growth slowed to ~7.9% in Q2 2026 and EPS missed estimates. The valuation has reset with it: as of October 16, 2026 the trailing P/E is ~30 and the forward P/E ~26, down from the high 30s and low 30s in July, and the dividend yield has risen to ~2.2%. That is still a premium to the broader market for recurring-revenue quality, and the Q3 report on October 21, 2026 (consensus ~$0.35 of EPS on ~$1.11 billion of revenue) is the next test.

How do you decide if ROL is a buy?

Rather than asking whether ROL is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the bull case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold ROL indirectly through an index or sector ETF before adding more.

What would change your mind on ROL

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

Bull case breaks if: Recurring, non-discretionary demand stalls in the reported numbers rather than in the narrative around them.
Bear case breaks if: valuation is the central risk: ROL trades at a premium earnings multiple (about 30 times trailing earnings in October 2026) that assumes years of consistent growth, and 2026 has shown how a slowdown compresses it: after growth eased to ~8% and Q2 EPS missed, the market value fell from ~$20 billion in July to ~$16.1 billion fails to materialise over several reporting periods while the drivers keep compounding.
Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the ROL stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about ROL against your real portfolio and see your actual exposure before deciding.

Investing in Rollins with AI

Connect the broker you already use and ask Walnut's AI how ROL fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

Does ROL fit me?

FAQ

Is ROL a good stock to buy right now?

That depends on which case you find more convincing, and both are on this page. The bull case rests on Recurring, non-discretionary demand, with revenue (ttm) at ~$3.92B. The bear case rests on valuation is the central risk: ROL trades at a premium earnings multiple (about 30 times trailing earnings in October 2026) that assumes years of consistent growth, and 2026 has shown how a slowdown compresses it: after growth eased to ~8% and Q2 EPS missed, the market value fell from ~$20 billion in July to ~$16.1 billion. Analysts covering it are spread from $27.00 to $66.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell ROL?

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Valuation is the central risk: ROL trades at a premium earnings multiple (about 30 times trailing earnings in October 2026) that assumes years of consistent growth, and 2026 has shown how a slowdown compresses it: after growth eased to ~8% and Q2 EPS missed, the market value fell from ~$20 billion in July to ~$16.1 billion. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $27.00, -19.3% from the $33.45 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for ROL?

Recurring, non-discretionary demand. Pest and termite control is largely a need-to-do service, not a discretionary purchase, so a large portion of Rollins revenue recurs on contracts and repeat routes. The most optimistic analyst target on ROL is $66.00, +97.3% from the $33.45 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for ROL?

What does Rollins do?

Rollins, Inc., through its subsidiaries, provides pest and wildlife control services and protection to residential and commercial customers in the United States and internationally.

What would have to change for ROL to stop being worth holding?

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Recurring, non-discretionary demand) stalling in the reported numbers rather than in the narrative, the risk above (valuation is the central risk: ROL trades at a premium earnings multiple (about 30 times trailing earnings in October 2026) that assumes years of consistent growth, and 2026 has shown how a slowdown compresses it: after growth eased to ~8% and Q2 EPS missed, the market value fell from ~$20 billion in July to ~$16.1 billion) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Rollins (ROL) do?

Rollins provides pest and termite control services to homes and businesses through brands led by Orkin, plus HomeTeam Pest Defense, Clark Pest Control, Fox Pest Control, and many others. Its revenue is largely recurring, tied to contracts and repeat service routes across the US and several international markets.

Is ROL a good long-term holding?

Rollins has the traits investors often prize in a long-term compounder: recurring, non-discretionary revenue, steady organic growth, consistent free cash flow, and a rising dividend. The main tradeoff is a premium valuation that already reflects that quality. Whether it fits a given portfolio depends on your goals and risk tolerance, not on any recommendation here.

Why is ROL's P/E ratio so high?

Rollins trades at a trailing P/E of about 30 as of October 16, 2026 (down from the high 30s in July) because the market pays up for its recurring revenue, recession resistance, and long record of consistent growth. A premium multiple means a lot of good news is already priced in, and 2026 showed the flip side: when growth slowed and Q2 EPS missed, the multiple compressed. Future returns depend partly on whether growth keeps meeting expectations.

Walnut is informational, not investment advice, and gives no verdict on ROL. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.